Compare ARK Genomic Revolution ETF (ARKG) vs Canadian Natural Resources Ltd. (CNQ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Canadian Natural Resources Ltd. — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Canadian Natural Resources Ltd. trades at $42.2 (market cap $86.83B). The key difference: Canadian Natural Resources Ltd. pays a 4.21% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Canadian Natural Resources Ltd. nearer its low. Which is the better fit depends on your goals.
| ARKG | CNQ | |
|---|---|---|
Sector | Sector/Thematic | Energy |
52-Week High | $43.57 | $50.55 |
52-Week Low | $23.09 | $29.31 |
Market Cap | — | $86.83B |
Enterprise Value | — | $98.06B |
Dividend Yield | — | 4.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
CNQ trades at $41.81, down 0.17% on the day, with a bullish technical signal and strong fundamentals. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $0.85 exceeding the $0.74 estimate. Valuation metrics appear attractive with a P/E of 11.8 and EV/EBITDA of 6.54, while profitability remains high with a net income margin of 24.5% and ROE of 25.81%.
The outlook is positive given consistent earnings outperformance, a 75% analyst buy rating, and strong free cash flow supporting shareholder returns. Key risks include oil price volatility and rising debt levels, but the company's operational stability and dividend yield near 4% provide a cushion for investors seeking energy exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Canadian Natural Resources Ltd.
Canadian Natural Resources is one of the largest oil and natural gas producers in western Canada, supplemented by operations in the North Sea and Offshore Africa. The company's portfolio includes light and medium oil, heavy oil, bitumen, synthetic oil, natural gas liquids, and natural gas. Production averaged 1.16 million barrels of oil equivalent per day in 2020, and the company estimates that it holds over 11.5 billion boe of proven and probable crude oil and natural gas reserves.
Read more on CNQ →
